Home | Login | Subscribe Today!Jul. 3, 2009
 Newsroom

For over twenty years, Therapeutic Research Center has provided reliable, concise and useful advice to enhance patient care. Therapeutic Research Center and Therapeutic Research Faculty are well known for their strict policy against accepting any form of advertising, or support. All Therapeutic Research publications, continuing education courses and services are based on scientific evidence without any outside commercial influence. The researchers, reviewers, specialists, and editors provide recommendations to hundreds of thousands of health professionals, throughout many countries. The staff nurture creative innovations and are happy to announce the following initiatives:

Prescriber's Letter Press Releases
Prescriber's Letter Helps Increase Immunization and Reduce Infectious Outbreaks
September 14, 2007 — Stockton, CA — Infectious disease experts predict that failure to properly immunize Americans is putting us on the verge of more outbreaks. A significant factor is that many clinicians do not know the latest vaccination recommendations against contagious diseases. Continue reading... Download PDF
 
Prescriber's Letter Clarifies Avandia Heart Attack Warning with Stepwise Diabetes Treatment Algorithm for Prescribers
May 29, 2007 — Stockton, CA — Prescribers and diabetes patients alike are wondering what to make of recent media reports of a New England Journal of Medicine study suggesting Avandia (rosiglitazone) increases heart attack risk by 43% in diabetes patients. Avandia, an oral agent for type 2 diabetes, accounted for more than 3 billion dollars in worldwide sales last year. Critics are jumping to liken these N Engl J Med study results to the early cardiovascular concerns seen with Vioxx that ultimately led to its removal from the market. Continue reading... Download PDF
 
Related Press Releases
New Scientific Rating System Helps Consumers and Professionals Find High-Quality Dietary Supplements and Natural Medicines
June 9, 2008 — Stockton, CA — Consumers shopping the dietary supplement aisle and healthcare professionals advising patients using natural medicines face difficult questions. Of the hundreds or thousands of products on the shelf or online, which ones work? Are they safe? Do they even contain the ingredients listed on the label? Continue reading... Download PDF
 
Avoiding Hidden Safety Risks with Fatty Fish and Omega-3 Fish Oil Supplements
August 13, 2007 — Stockton, CA — Health conscious individuals are looking carefully at dietary fish oil intake and omega-3 fatty acid supplements. Research shows eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) found in some fish can lower triglycerides, prevent heart disease and may help lower the risk of cardiac death. Continue reading...
 
Neurology and Pharmacy Experts Reexamining Substitution of Antiepileptic Drugs
June 28, 2007 — Stockton, CA — A growing controversy over substituting generic antiepileptic drugs (AEDs) for their brand name counterparts will impact pharmacists, prescribers, and patients with epilepsy. Continue reading... Download PDF
 
View Archived News Items
Subscribe to Prescriber's Letter Today
Prescriber's Letter eLetter
   
Home | Search or Browse | Index of Topics | Privacy Policy | Email Us
Therapeutic Research Center
3120 W. March Lane, PO Box 8190, Stockton, CA 95208, Tel:(209) 472-2240 Fax:(209) 472-2249
Copyright © 1995-2009, All rights reserved.